Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 28 September 1999
Vol. 1999, Issue 1, p. tw7
[DOI: 10.1126/stke.1999.1.tw7]

EDITORS' CHOICE

Receptor biology Antagonism in the family

The receptor tyrosine kinase p185HER-2 is implicated in several human carcinomas. When overexpressed, this receptor dimerizes in the absence of a known ligand and becomes constitutively activated. This receptor can also heterodimerize with ligand-activated members of the structurally related epidermal growth factor receptor family. Doherty et al. have identified a naturally occurring inhibitor of p185HER-2 called herstatin. This secreted protein is the product of an alternatively spliced HER-2 transcript that encodes part of the receptor extracellular domain as well as residues encoded by an intron. By binding to p185HER-2, herstatin may inhibit receptor dimerization. Hence, herstatin may have value as a growth inhibitor in anti-cancer therapies.

Doherty, J.K., Bond, C., Jardim, A., Adelman, J.P., Clinton, G.M. (1999) The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor. Proc. Natl. Acad. Sci. U.S.A. 96: 10869-10874. [Abstract] [Full Text]

Citation: Antagonism in the family. Sci. STKE 1999, tw7 (1999).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882